Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CGTX
COGNITION THERAPEUTICS INC
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$0.96
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$91.29M
RECENT INSIDER TRADES
2026-05-04
· Doyle John Brendan
(Chief Financial Officer)
· OTHER
2026-04-20
· Caggiano Anthony
(Chief Medical Officer)
· BUY
2026-04-20
· Ricciardi Lisa
(CEO & President)
· BUY
2026-04-20
· Doyle John Brendan
(Chief Financial Officer)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
72
Shares held
26,144,842
Value
$30.64M
Percent of shares outstanding
27.49%
As of quarter end
2026-06-30
RECENT NEWS
H.C. Wainwright reiterates Cognition Therapeutics stock rating ahead of FDA meeting
Cognition Therapeutics schedules FDA meeting on Phase 3 endpoints for zervimesine
COGNiTiON Science and Discovery Center Renews Certified Autism Center™ Status
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS